OpioidRedoxStudyII
NCT07338084 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2026-01-13
Summary
This observational study aims to examine the relationship between opioid use and redox balance in adults. Redox balance reflects the level of oxidative stress in the body, which is known to play an important role in many biological processes and diseases.
Participants who use opioids will be included in the study. No experimental treatment or changes to current medical care will be provided as part of this study. Biological samples may be collected to assess redox-related biomarkers, and relevant clinical and demographic information will be recorded.
The results of this study are expected to improve understanding of how opioid exposure is associated with redox balance in adults. This information may help inform future research on the biological effects of opioids and potential strategies to reduce harm associated with long-term opioid use.
Conditions
- Oxidative Stress
- Opioid Use
Sponsors & Collaborators
-
Pavol Jozef Safarik University
collaborator OTHER -
F.D.Roosevelt Banska Bystrica Slovak Republic
collaborator UNKNOWN -
Europainclinics z.ú.
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2026-12-30
- Completion
- 2029-12-31
Countries
- Slovakia
Study Locations
More Related Trials
-
Morphine or Fentanyl for Refractory Dyspnea in COPD
NCT03834363 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Unintended Prolonged Opioid Use
NCT04024397 ·Status: COMPLETED
-
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167699 ·Status: COMPLETED ·Phase: PHASE3
-
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
NCT04948307 ·Status: COMPLETED ·Phase: NA
-
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
NCT05706311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants
NCT02745912 ·Status: COMPLETED ·Phase: PHASE1
-
Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
NCT04287062 ·Status: COMPLETED ·Phase: PHASE2
-
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
NCT01967641 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Injectable Extended Release Naltrexone Treatment
NCT02324725 ·Status: COMPLETED ·Phase: PHASE4
-
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
NCT01197261 ·Status: COMPLETED ·Phase: PHASE2
-
Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis
NCT02452437 ·Status: UNKNOWN ·Phase: PHASE4
-
Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction
NCT01562353 ·Status: UNKNOWN
-
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
NCT02559973 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
NCT02357901 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users
NCT01030406 ·Status: COMPLETED ·Phase: PHASE2
-
Oxycodone User Registry (OUR)
NCT00978328 ·Status: COMPLETED
-
Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse
NCT00734461 ·Status: COMPLETED ·Phase: PHASE2
-
Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
NCT02136784 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
NCT00463047 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
NCT01903005 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
NCT01358526 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Computerized Opioid Overdose Prevention Program
NCT02040077 ·Status: COMPLETED ·Phase: NA
-
Sensory Outcomes in Active Substance Users
NCT06639438 ·Status: RECRUITING
-
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
NCT02751762 ·Status: COMPLETED
-
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
NCT03936985 ·Status: COMPLETED